scispace - formally typeset
M

M. Desai

Researcher at Children's of Alabama

Publications -  32
Citations -  1205

M. Desai is an academic researcher from Children's of Alabama. The author has contributed to research in topics: Cystic fibrosis & Medicine. The author has an hindex of 12, co-authored 21 publications receiving 928 citations. Previous affiliations of M. Desai include Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Josephine M. Bryant, +90 more
- 11 Nov 2016 - 
TL;DR: Using whole-genome analysis of a global collection of clinical isolates, it is shown that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones that have spread globally.

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

TL;DR: In this paper, the authors used whole-genome analysis of a global collection of clinical isolates to show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones.
Journal ArticleDOI

Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth.

TL;DR: The change in resistance of Burkholderia cepacia to ceftazidime and to ciprofloxacin during the exponential phase and up to the onset of stationary phase was assessed along the growth curve in batch culture.
Journal ArticleDOI

Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare

TL;DR: How it came to understand the pathogen, how it is currently treated and drug resistance mechanisms and novel treatments currently in development are discussed and improved in vivo methods of efficacy testing are examined.
Journal ArticleDOI

Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome

TL;DR: The use of recombinant human DNase (rhDNase) has been shown to reduce sputum viscosity, improve pulmonary function, and results in a small reduction in acute respiratory exacerbations requiring intravenous antibiotics in many patients with cystic fibrosis as mentioned in this paper.